The Impact of Bariatric Surgery on Adipocyte Metabolism

Clinical Trial ID: NCT04242524

Description

The purpose of this study is to understand how daily rhythms of behavior affect the expression of genes in fat cells, and how these daily cycles affect the way fat cells respond to insulin (a hormone that controls blood sugar levels) before and after bariatric surgery.

Bariatric surgery as a means of weight loss has become increasingly popular over the last 10-15 years. In addition to promoting weight loss, bariatric surgery has become increasingly recognized for use in the management of diabetes. Recent studies have indicated that bariatric surgery can result in a marked improvement in insulin sensitivity before long term weight loss is attained. The goal of this project is to delineate the changes in the insulin responsiveness of subcutaneous adipocytes obtained by needle biopsy 2 weeks prior to surgery vs. 12 weeks after bariatric surgery, which could account for improvements in overall insulin sensitivity seen before any long-term sustained weight loss has occurred. We will also examine gene expression in adipocytes (fat cells).


Criteria

Obese Subjects Inclusion Criteria: - 18-55 years old - Female - BMI greater than 40 kg/m2 - Scheduled for bariatric surgery at the Center for the Surgical Treatment of Obesity at the University of Chicago - Signed informed consent Exclusion Criteria: - Male - Diagnosed with a systemic illnesses, including heart, renal, liver, or malignant disease - Uncontrolled hypertension (blood pressure greater than 140 mmHg systolic and 90 mmHg diastolic without medication) - use of beta blockers - hemoglobin less than 11.5g/dL - known allergy to lidocaine - pregnancy - lactation - Subjects will not have undergone surgery, donated a unit of blood, or participated in another clinical study within the last 4 weeks prior to consent. - Post-menopausal Non-Obese Subjects Inclusion Criteria: - 18-55 years old - Female - BMI less than 30 kg/m2 - Signed informed consent Exclusion Criteria: - Male - Diagnosed with a systemic illnesses, including heart, renal, liver, or malignant disease - Uncontrolled hypertension (blood pressure greater than 140 mmHg systolic and 90 mmHg diastolic without medication) - use of beta blockers - hemoglobin less than 11.5g/dL - known allergy to lidocaine - pregnancy - lactation - Subjects will not have undergone surgery, donated a unit of blood, or participated in another clinical study within the last 4 weeks prior to consent. - Post-menopausal

  • Start Date

    2015-03-26

  • Last Updated

    2020-01-23

  • Sponsor

    University of Chicago

  • Condition Name

    Obesity

Learn about this trial.

Check the eligibility requirements, study details, and more.

Related Trials

Different trials target different symptoms, condition types, and patients. Learn more about other emergeing treatments being investigated now.